NCT04029454
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- District sanitaire de Dafra Bobo-Dioulasso, Dafra, Burkina Faso
- District sanitaire de Do Bobo-Dioulasso, Do, Burkina Faso
Clinical trial condition
Hepatitis B
Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.
458 public trials
28 recruiting studies
Hepatitis B trial results
NCT03248622
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) Bethesda, Maryland, United States
NCT03797014
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
- Locations
-
- Institute of Human Virology Clinical Research Unit Baltimore, Maryland, United States
- Newlands Health Philadelphia, Pennsylvania, United States
NCT03702998
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +30 more
- Locations
-
- Prince of Wales Hospital Shatin, Hong Kong
NCT05002907
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +23 more
- Locations
-
- General Hospital of Cayenne Cayenne, French Guiana
- Foundation for Scientific Research Suriname (SWOS) Paramaribo, Suriname
NCT00401336
- Conditions
- Alcohol Abuse, Alcohol-Related Disorders, Alcoholism, +27 more
- Locations
-
- CHU Angers Angers, France
- Hôpital Beaujon Clichy, France
- Hôpital Huriez Lille, France
- Hôpital Edouard Herriot Lyon, France
NCT04449029
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Decatur, Georgia, United States
Completed
HBV-HIV Coinfection Research Network
NCT01924455
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
- Locations
-
- University of California San Francisco, California, United States
- Johns Hopkins University Baltimore, Maryland, United States
- NIDDK Bethesda, Maryland, United States
- Mass General Hospital Boston, Massachusetts, United States
NCT01369212
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Cedars Sinai Medical Center Los Angeles, California, United States
- University of California Los Angeles Los Angeles, California, United States
- California Pacific Medical Center San Francisco, California, United States
- University of California San Francisco San Francisco, California, United States
Completed
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
NCT05275465
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Q-Pharm Pty Ltd (Nucleus Network Pty Ltd) Brisbane, Queensland, Australia